Primary central nervous system lymphoma differential diagnosis: Difference between revisions
Line 14: | Line 14: | ||
*[[Neurosarcoidosis]] | *[[Neurosarcoidosis]] | ||
It is a relatively common occurrence for radiologists to be asked to distinguish between [[toxoplasmosis|cerebral toxoplasmosis]] and primary central nervous system lymphoma in patients with HIV/AIDS. Treatment is clearly different and thus accurate interpretation of CT and MRI is essential.<ref name=toxoplasmossisvsprimarycnslymphoma1>Toxoplasmosis vs CNS lymphoma. Dr Henry Knipe and Dr Praveen Jha et al. Radiopaedia 2016. http://radiopaedia.org/articles/toxoplasmosis-vs-lymphoma. Accessed on February 17, 2016</ref> In many instances appearances are classic and pose little problem, however, in 50-80% of cases the appearances can be very similar requiring careful interpretation | It is a relatively common occurrence for radiologists to be asked to distinguish between [[toxoplasmosis|cerebral toxoplasmosis]] and primary central nervous system lymphoma in patients with HIV/AIDS. Treatment is clearly different and thus accurate interpretation of CT and MRI is essential.<ref name=toxoplasmossisvsprimarycnslymphoma1>Toxoplasmosis vs CNS lymphoma. Dr Henry Knipe and Dr Praveen Jha et al. Radiopaedia 2016. http://radiopaedia.org/articles/toxoplasmosis-vs-lymphoma. Accessed on February 17, 2016</ref> In many instances appearances are classic and pose little problem, however, in 50-80% of cases the appearances can be very similar requiring careful interpretation. Below are helpful distinguishing features.<ref name=toxoplasmossisvsprimarycnslymphoma1>Toxoplasmosis vs CNS lymphoma. Dr Henry Knipe and Dr Praveen Jha et al. Radiopaedia 2016. http://radiopaedia.org/articles/toxoplasmosis-vs-lymphoma. Accessed on February 17, 2016</ref> | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width:1000px align=center" | {| style="border: 0px; font-size: 90%; margin: 3px; width:1000px align=center" | ||
Line 24: | Line 24: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |'''Characteristics of lesion''' | | style="padding: 5px 5px; background: #DCDCDC;" |'''Characteristics of lesion''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Single lesion with subependymal spread | | style="padding: 5px 5px; background: #F5F5F5;" |'''Single''' lesion with '''subependymal spread''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Multiple lesions scattered though [[basal ganglia]] and | | style="padding: 5px 5px; background: #F5F5F5;" |'''Multiple''' lesions scattered though [[basal ganglia]] and '''corticomedullary junction''' | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |'''Enhancement on CT and MRI''' | | style="padding: 5px 5px; background: #DCDCDC;" |'''Enhancement on CT and MRI''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Solid enhancement, however primary CNS lymphoma patients with HIV/AIDS may demonstrate ring enhancement also. | | style="padding: 5px 5px; background: #F5F5F5;" |'''Solid''' enhancement, however primary CNS lymphoma patients with HIV/AIDS may demonstrate ring enhancement also. | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Ring or nodular enhancement | | style="padding: 5px 5px; background: #F5F5F5;" |'''Ring''' or '''nodular''' enhancement | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |'''Hemorrhage''' | | style="padding: 5px 5px; background: #DCDCDC;" |'''Hemorrhage''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |No [[hemorrhage]] before treatment | | style="padding: 5px 5px; background: #F5F5F5;" |'''No''' [[hemorrhage]] before treatment | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Hemorrhage]] occasionally occurs mostly in periphery of lesion | | style="padding: 5px 5px; background: #F5F5F5;" |[[Hemorrhage]] occasionally occurs mostly in periphery of lesion | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |'''Single-photon emission computed tomography (SPECT)''' | | style="padding: 5px 5px; background: #DCDCDC;" |'''Single-photon emission computed tomography (SPECT)''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Thallium SPECT positive | | style="padding: 5px 5px; background: #F5F5F5;" |Thallium SPECT '''positive''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Thallium SPECT negative | | style="padding: 5px 5px; background: #F5F5F5;" |Thallium SPECT '''negative''' | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |'''Magnetic resonance spectroscopy (MRS)''' | | style="padding: 5px 5px; background: #DCDCDC;" |'''Magnetic resonance spectroscopy (MRS)''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |MRS: markedly increased [[choline]] (Cho) | | style="padding: 5px 5px; background: #F5F5F5;" |MRS: markedly '''increased''' [[choline]] (Cho) | ||
| style="padding: 5px 5px; background: #F5F5F5;" |MRS: decreased [[choline|Cho]] | | style="padding: 5px 5px; background: #F5F5F5;" |MRS: '''decreased''' [[choline|Cho]] | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" |'''Magnetic resonance perfusion''' | | style="padding: 5px 5px; background: #DCDCDC;" |'''Magnetic resonance perfusion''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |MR perfusion: increased relative cerebral blood volume (rCBV) | | style="padding: 5px 5px; background: #F5F5F5;" |MR perfusion: '''increased''' relative cerebral blood volume (rCBV) | ||
| style="padding: 5px 5px; background: #F5F5F5;" |MR perfusion: decreased rCBV | | style="padding: 5px 5px; background: #F5F5F5;" |MR perfusion: '''decreased''' rCBV | ||
|} | |} | ||
Revision as of 19:34, 17 February 2016
Primary central nervous system lymphoma Microchapters |
Differentiating Primary Central Nervous System Lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Primary central nervous system lymphoma differential diagnosis On the Web |
American Roentgen Ray Society Images of Primary central nervous system lymphoma differential diagnosis |
FDA on Primary central nervous system lymphoma differential diagnosis |
CDC on Primary central nervous system lymphoma differential diagnosis |
Primary central nervous system lymphoma differential diagnosis in the news |
Blogs on Primary central nervous system lymphoma differential diagnosis |
Directions to Hospitals Treating Primary central nervous system lymphoma |
Risk calculators and risk factors for Primary central nervous system lymphoma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Differentiating Primary Central Nervous System Lymphoma from other Diseases
Primary central nervous system lymphoma must be differentiated from:[1]
- Secondary CNS lymphoma: indistinguishable on imaging, however it tends to involve more leptomeninges (~2/3 of cases)
- Cerebral toxoplasmosis
- Glioblastoma multiforme (butterfly glioma)
- Tumefactive demyelinating lesion
- Cerebral abscess
- Neurosarcoidosis
It is a relatively common occurrence for radiologists to be asked to distinguish between cerebral toxoplasmosis and primary central nervous system lymphoma in patients with HIV/AIDS. Treatment is clearly different and thus accurate interpretation of CT and MRI is essential.[2] In many instances appearances are classic and pose little problem, however, in 50-80% of cases the appearances can be very similar requiring careful interpretation. Below are helpful distinguishing features.[2]
Differentiating point | Primary CNS Lymphoma | Cerebral Toxoplasmosis |
---|---|---|
Characteristics of lesion | Single lesion with subependymal spread | Multiple lesions scattered though basal ganglia and corticomedullary junction |
Enhancement on CT and MRI | Solid enhancement, however primary CNS lymphoma patients with HIV/AIDS may demonstrate ring enhancement also. | Ring or nodular enhancement |
Hemorrhage | No hemorrhage before treatment | Hemorrhage occasionally occurs mostly in periphery of lesion |
Single-photon emission computed tomography (SPECT) | Thallium SPECT positive | Thallium SPECT negative |
Magnetic resonance spectroscopy (MRS) | MRS: markedly increased choline (Cho) | MRS: decreased Cho |
Magnetic resonance perfusion | MR perfusion: increased relative cerebral blood volume (rCBV) | MR perfusion: decreased rCBV |
References
- ↑ Differential diagnosis of primary central nervous system lymphoma. Dr Amir Rezaee and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/primary-cns-lymphoma. Accessed on February 17, 2016
- ↑ 2.0 2.1 Toxoplasmosis vs CNS lymphoma. Dr Henry Knipe and Dr Praveen Jha et al. Radiopaedia 2016. http://radiopaedia.org/articles/toxoplasmosis-vs-lymphoma. Accessed on February 17, 2016